This inventor holds 1 USPTO granted patent. Top assignee: Pharmacia & Upjohn Ab. Active years: 1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998
Title: Kristina Lima Lie: Innovator in Protein Production
Introduction
Kristina Lima Lie is a notable inventor based in Stockholm, Sweden. She has made significant contributions to the field of biotechnology, particularly in the production of recombinant human proteins. Her innovative approach addresses critical challenges in protein production, showcasing her expertise and dedication to advancing medical science.
Latest Patents
Kristina Lima Lie holds a patent for a process aimed at enhancing the production of recombinant human proteins. The patent, titled "Process for producing a protein," presents a method for reducing the detrimental influence of certain proteases on protein production in cell cultures. This process involves adding an inhibitor of metal-dependent proteases or chymotrypsins to the cell culture medium. The resulting recombinant factor VIII produced through this method is particularly useful for treating patients with hemophilia A, providing a therapeutically effective solution for this condition.
Career Highlights
Kristina Lima Lie is associated with Pharmacia & Upjohn AB, where she has been instrumental in developing innovative solutions for protein production. Her work has not only contributed to the scientific community but has also had a significant impact on the pharmaceutical industry. With her expertise, she continues to push the boundaries of what is possible in biotechnology.
Collaborations
Throughout her career, Kristina has collaborated with esteemed colleagues, including Lars Adamson and Erik Walum. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas, further enhancing the impact of their work in the field.
Conclusion
Kristina Lima Lie's contributions to the field of protein production exemplify her commitment to innovation and excellence. Her patented process represents a significant advancement in biotechnology, particularly for the treatment of hemophilia A. Through her work at Pharmacia & Upjohn AB and her collaborations with fellow researchers, she continues to make strides in improving medical treatments and outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile